Evidence map›Paper›PMID 41487157›Full record

ArticleACS omega2025

ProtPSP: Determination of Protein Phosphorylation Sites with the Protein Large Language Model.

Bifeng Guan, Lei Guo, Thomas Ka-Yam Lam, Zhuang Xiong, Shangyi Luo, Yang Sun, Kaizhi Chen

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bifeng GuanCollege of Computer and Data Science, Fuzhou University, Fuzhou 350108, China.
Lei GuoCollege of Computer and Data Science, Fuzhou University, Fuzhou 350108, China.ORCID https://orcid.org/0000-0002-8032-8748
Thomas Ka-Yam LamState Key Laboratory of Environmental and Biological Analysis, Department of Chemistry, Hong Kong Baptist University, Hong Kong 999077, China.ORCID https://orcid.org/0000-0002-0728-0266
Zhuang XiongInterdisciplinary Institute for Medical Engineering, Fuzhou University, Fuzhou 350108, China.
Shangyi LuoInterdisciplinary Institute for Medical Engineering, Fuzhou University, Fuzhou 350108, China.
Yang SunDepartment of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350104, China.
Kaizhi ChenCollege of Computer and Data Science, Fuzhou University, Fuzhou 350108, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate identification of phosphorylation sites is fundamental for advancing the study of protein phosphorylation, which plays a critical role in elucidating protein function and facilitating rational drug design. While mass spectrometry-based experimental techniques are considered the effective method for phosphorylation site identification, their widespread application is often hindered by high costs, limited throughput, and the requirement for specialized equipment. Computational prediction methods have become a popular alternative strategy for providing candidate phosphorylation sites by inferring their presence from the entire protein sequence. However, many current methods struggle to extract sufficient contextual features, limiting their predictive reliability in complex biological settings. To address these issues, we present a novel protein large language model (pLLM)-based model, called ProtPSP, for phosphorylation site prediction. By leveraging a pretrained pLLM, ProtPSP effectively captures complex sequence contexts that conventional models trained on limited phosphorylation data may miss. Comprehensive benchmarking on curated data sets demonstrates that ProtPSP achieves reliable phosphorylation site prediction for both serine/threonine and tyrosine sites, outperforming other commonly used methods across multiple evaluation metrics. Ablation studies substantiate the critical contribution of both pLLM-driven features and the fusion model architecture to overall performance improvements. Moreover, case studies demonstrate that ProtPSP consistently identifies all true phosphorylation sites, underscoring its significant potential as a complementary approach to mass spectrometry-based techniques in biomedical research and drug discovery.

Identifiers

PMID41487157
PMCPMC12756753

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.